In spite of great advancements in the field of biomaterials and in surgical techniques, the implant of medical devices is still associated with a high risk of bacterial infection. Implant-associated osteomyelitis is a deep infection of bone around the implant. The continuous inflammatory destruction of bone tissues characterizes this serious bone infectious disease. Staphylococcus aureus and Staphylococcus epidermidis are the most prevalent etiologic agents of implant-associated infections, together with the emerging pathogen Staphylococcus lugdunensis. Various interactions between staphylococci, osteoblasts, and phagocytes occurring in the peri-prosthesis environment play a crucial role in the pathogenesis of implant-associated osteomyelitis. Here we focus on two main events: internalization of staphylococci into osteoblasts, and bacterial interactions with phagocytic cells.
FinlayB.B., CossartP.Exploitation of mammalian host cell functions by bacterial pathogens. Science.1997; 276(5313): 718–725.
2.
KubicaM., GuzikK., KozielJ.. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One.2008; 3(1): e1409.
3.
HauckC.R., OhlsenK.Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol.2006; 9(1): 5–11.
4.
SinhaB., FraunholzM.Staphylococcus aureus host cell invasion and post-invasion events. Int J Med Microbiol.2010; 300(2-3): 170–175.
5.
TuchscherrL., HeitmannV., HussainM.. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis.2010; 202(7): 1031–1040.
6.
JevonM., GuoC., MaB.. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infect Immun.1999; 67(5): 2677–2681.
7.
MasseyR.C., KantzanouM.N., FowlerT., Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol.2001; 3(12): 839–851.
8.
AgererF., MichelA., OhlsenK., HauckC.R.Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J Biol Chem.2003; 278(43): 42524–42531.
9.
KintarakS., WhawellS.A., SpeightP.M., PackerS., NairS.P.Internalization of Staphylococcus aureus by human keratinocytes. Infect Immun.2004; 72(10): 5668–5675.
10.
TestoniF., MontanaroL., PoggiA., VisaiL., CampocciaD., ArciolaC.R.Internalization by osteoblasts of two Staphylococcus aureus clinical isolates differing in their adhesin gene pattern. Int J Artif Organs.2011; 34(9): 789–798.
11.
KhalilH., WilliamsR.J., StenbeckG., HendersonB., MeghjiS., NairS.P.Invasion of bone cells by Staphylococcus epidermidis. Microbes Infect.2007; 9(4): 460–465.
12.
HirschhausenN., SchlesierT., SchmidtM.A., GötzF., PetersG., HeilmannC.A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol.2010; 12(12): 1746–1764.
13.
SzabadosF., MarlinghausL., KorteM., NeumannS., KaaseM., GatermannS.G.Fbl is not involved in the invasion of eukaryotic epithelial and endothelial cells by Staphylococcus lugdunensis. FEMS Microbiol Lett.2011; 324(1): 48–55.
14.
LowyF.D.Staphylococcus aureus infections. N Engl J Med.1998; 339(8): 520–532.
NuzzoI., SangesM.R., FolgoreA., CarratelliC.R.Apoptosis of human keratinocytes after bacterial invasion. FEMS Immunol Med Microbiol.2000; 27(3): 235–240.
17.
WessonC.A., DeringerJ., LiouL.E., BaylesK.W., BohachG.A., TrumbleW.R.Apoptosis induced by Staphylococcus aureus in epithelial cells utilizes a mechanism involving caspases 8 and 3. Infect Immun.2000; 68(5): 2998–3001.
18.
MenziesB.E., KourtevaI.Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol.2000; 29(1): 39–45.
19.
AlexanderE.H., BentoJ.L., HughesF.M.Jr., MarriottI., HudsonM.C., BostK.L.Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun.2001; 69(3): 1581–1586.
AkatsuT., TakahashiN., UdagawaN.. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res.1991; 6(2): 183–189.
22.
KobayashiY., MizoguchiT., TakeI., KuriharaS., UdagawaN., TakahashiN.Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem.2005; 280(12): 11395–11403.
23.
WadaT., NakashimaT., HiroshiN., PenningerJ.M.RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med.2006; 12(1): 17–25.
24.
SomayajiS.N., RitchieS., SahraeiM., MarriottI., HudsonM.C.Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun.2008; 76(11): 5120–5126.
25.
MeghjiS., CreanS.J., HillP.A.. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogeesesis: possible role in S. aureus-induced boneBr J Rheumatol pathology.1998; 37: 1095–1101.
26.
MontonenM., LiT.F., LukinmaaP.L.. RANKL and cathepsin K in diffuse sclerosing osteomyelitis of the mandible. J Oral Pathol Med.2006; 35(10): 620–625.
27.
SimonetW.S., LaceyD.L., DunstanC.R.. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell.1997; 89(2): 309–319.
28.
ClaroT., WidaaA., O'SeaghdhaM.. Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One.2011; 6(4): e18748.
29.
NairS., SongY., MeghjiS.. Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity. J Bone Miner Res.1995; 10(5): 726–734.
30.
NairS.P., MeghjiS., WilsonM.. Clinical isolates of Staphylococcus aureus have osteolytic surface proteins and a proportion of the population have antibodies that block this activity: is this of prognostic significance?Br J Rheumatol.1997; 36(3): 328–332.
31.
MeghjiS., CreanS.J., NairS.. Staphylococcus epidermidis produces a cell-associated proteinaceous fraction which causes bone resorption by a prostanoid-independent mechanism: relevance to the treatment of infected orthopaedic implants. Br J Rheumatol.1997; 36(9): 957–963.
32.
LiN.H., OuchiY., OkamotoY.. Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells. Biochem Biophys Res Commun.1991; 179(1): 236–242.
33.
PivirottoL.A., CisselD.S., KeetingP.E.Sex hormones mediate interleukin-1 beta production by human osteoblastic HOBIT cells. Mol Cell Endocrinol.1995; 111(1): 67–74.
34.
LöwikC.W., van der PluijmG., BloysH.. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun.1989; 162(3): 1546–1552.
35.
IshimiY., MiyauraC., JinC.H.. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol.1990; 145(10): 3297–3303.
36.
LittlewoodA.J., RussellJ., HarveyG.R., HughesD.E., RussellR.G., GowenM.The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology.1991; 129(3): 1513–1520.
37.
GowenM., ChapmanK., LittlewoodA., HughesD., EvansD., RussellG.Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology.1990; 126(2): 1250–1255.
38.
Littlewood-EvansA.J., HattenbergerM.R., LüscherC., PatakiA., ZakO., O'ReillyT.Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun.1997; 65(8): 3438–3443.
39.
UdagawaN., HorwoodN.J., ElliottJ.. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med.1997; 185(6): 1005–1012.
40.
BostK.L., RampW.K., NicholsonN.C., BentoJ.L., MarriottI., HudsonM.C.Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis.1999; 180(6): 1912–1920.
41.
EllingtonJ.K., ElhofyA., BostK.L., HudsonM.C.Involvement of mitogen-activated protein kinase pathways in Staphylococcus aureus invasion of normal osteoblasts. Infect Immun.2001; 69(9): 5235–5242.
42.
KanedaT., NojimaT., NakagawaM.. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J Immunol.2000; 165(8): 4254–4263.
43.
SudaK., UdagawaN., SatoN.. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol.2004; 172(4): 2504–2510.
44.
ModrowskiD., LomriA., MarieP.J.Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells. J Cell Physiol.1997; 170(1): 35–46.
45.
TakamatsuY., SimmonsP.J., MooreR.J., MorrisH.A., ToL.B., LévesqueJ.P.Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood.1998; 92(9): 3465–3473.
46.
WeirE.C., HorowitzM.C., BaronR., CentrellaM., KacinskiB.M., InsognaK.L.Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res.1993; 8(12): 1507–1518.
47.
KodamaH., NoseM., NiidaS., YamasakiA.Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med.1991; 173(5): 1291–1294.
48.
LiggettW.Jr., ShevdeN., AnklesariaP., SohoniS., GreenbergerJ., GlowackiJ.Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells. Stem Cells.1993; 11(5): 398–411.
49.
FrenckR.W., SarmanG., HarperT.E., BuescherE.S.The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. J Infect Dis.1990; 162(1): 109–114.
50.
DaleD.C., LilesW.C., SummerW.R., NelsonS.Review: granulocyte colony-stimulating factor—role and relationships in infectious diseases. J Infect Dis.1995; 172(4): 1061–1075.
51.
SpezialeP., PietrocolaG., RindiS.. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol.2009; 4(10): 1337–1352.
52.
BaierR.E., MeyerA.E., NatiellaJ.R., NatiellaR.R., CarterJ.M.Surface properties determine bioadhesive outcomes: methods and results. J Biomed Mater Res.1984; 18(4): 337–355.
FrançoisP., VaudauxP., FosterT.J., LewD.P.Host-bacteria interactions in foreign body infections. Infect Control Hosp Epidemiol.1996; 17(8): 514–520.
55.
FosterS.J.Molecular characterization and functional analysis of the major autolysin of Staphylococcus aureus 8325/4. J Bacteriol.1995; 177(19): 5723–5725.
56.
HeilmannC., HussainM., PetersG., GötzF.Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol.1997; 24(5): 1013–1024.
57.
BourgeoisI., CamiadeE., BiswasR.. Characterization of AtlL, a bifunctional autolysin of Staphylococcus lugdunensis with N-acetylglucosaminidase and N-acetylmuramoyl-l-alanine amidase activities. FEMS Microbiol Lett.2009; 290(1): 105–113.
58.
LentinoJ.R.Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis.2003; 36(9): 1157–1161.
59.
ArciolaC.R., AnY.H., CampocciaD., DonatiM.E., MontanaroL.Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs.2005; 28(11): 1091–1100.
60.
CampocciaD., MontanaroL., ArciolaC.R.The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials.2006; 27(11): 2331–2339.
61.
MontanaroL., TestoniF., PoggiA., VisaiL., SpezialeP., ArciolaC.R.Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int J Artif Organs.2011; 34(9): 781–788.
62.
CampocciaD., BaldassarriL., PiriniV., RavaioliS., MontanaroL., ArciolaC.R.Molecular epidemiology of Staphylococcus aureus from implant orthopaedic infections: ribotypes, agr polymorphism, leukocidal toxins and antibiotic resistance. Biomaterials.2008; 29(30): 4108–4116.
63.
MontanaroL., SpezialeP., CampocciaD.. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol.2011; 6(11): 1329–1349.
64.
ArciolaC.R., CampocciaD., SpezialeP., MontanaroL., CostertonJ.W.Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials.2012; 33(26): 5967–5982.
65.
ArciolaC.R., VisaiL., TestoniF.. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues. Int J Artif Organs.2011; 34(9): 771–780.
66.
ArciolaC.R., MontanaroL., CostertonJ.W.New trends in diagnosis and control strategies for implant infections. Int J Artif Organs.2011; 34(9): 727–736.
67.
McDevittD., FrancoisP., VaudauxP.E., FosterT.J.Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol.1994; 11237–248.
68.
PattiJ.M., JonssonH., GussB.. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem.1992; 267: 4766–4772.
69.
FosterT.J., HöökM.Surface protein adhesins of Staphylococcus aureus. Trends Microbiol.1998; 6(12): 484–488.
70.
PalmaM., HaggarA., FlockJ.I.Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol.1999; 181(9): 2840–2845.
71.
HussainM., BeckerK., von EiffC., SchrenzelJ., PetersG., HerrmannM.Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol.2001; 183(23): 6778–6786.
72.
LeeL.Y., LiangX., HöökM., BrownE.L.Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J Biol Chem.2004; 279(49): 50710–50716.
73.
SinhaB., FrançoisP.P., NüsseO.. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol.1999; 1(2): 101–117.
74.
FowlerT., WannE.R., JohD., JohanssonS., FosterT.J., HöökM.Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol.2000; 79(10): 672–679.
75.
Schwarz-LinekU., HöökM., PottsJ.R.The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol.2004; 52(3): 631–641.
76.
DziewanowskaK., CarsonA.R., PattiJ.M., DeobaldC.F., BaylesK.W., BohachG.A.Staphylococcal fibronectin binding protein interacts with heat shock protein 60 and integrins: role in internalization by epithelial cells. Infect Immun.2000; 68(11): 6321–6328.
77.
SinhaB., FrancoisP., QueY.A.. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun.2000; 68(12): 6871–6878.
78.
AhmedS., MeghjiS., WilliamsR.J., HendersonB., BrockJ.H., NairS.P.Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun.2001; 69(5): 2872–2877.
79.
EdwardsA.M., PottsJ.R., JosefssonE., MasseyR.C.Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog.2010; 6(6): e1000964.
80.
PeacockS.J., DayN.P., ThomasM.G., BerendtA.R., FosterT.J.Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect.2000; 41(1): 23–31.
81.
ArciolaC.R., CampocciaD., GamberiniS., BaldassarriL., MontanaroL.Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol Lett.2005; 246(1): 81–86.
82.
HussainM., HaggarA., PetersG.. More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect Immun.2008; 76(12): 5615–5623.
83.
JuutiK.M., SinhaB., WerbickC., PetersG., KuuselaP.I.Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis.2004; 189(9): 1574–1584.
84.
HussainM., SchäferD., JuutiK.M.. Expression of Pls (plasmin sensitive) in Staphylococcus aureus negative for pls reduces adherence and cellular invasion and acts by steric hindrance. J Infect Dis.2009; 1:200(1): 107–17.
85.
De WitD., MullaR., CowieM.R., MasonJ.C., DaviesK.A.Vertebral osteomyelitis due to Staphylococcus epidermidis. Br J Rheumatol.1993; 32(4): 339–341.
86.
GaldbartJ.O., MorvanA., DesplacesN., el SolhN.Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses. J Clin Microbiol.1999; 37(5): 1306–1312.
87.
CarekP.J., DickersonL.M., SackJ.L.Diagnosis and management of osteomyelitis. Am Fam Physician.2001; 63(12): 2413–2420.
88.
ArrecubietaC., LeeM.H., MaceyA., FosterT.J., LowyF.D.SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem.2007; 282: 18767–18776.
89.
PonnurajK., BowdenM.G., DavisS.. A “dock, lock, and latch” structural model for a staphylococcal adhesin binding to fibrinogen. Cell.2003; 115(2): 217–228.
90.
CucarellaC., SolanoC., ValleJ., AmorenaB., LasaI., PenadésJ.R.Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol.2001; 183(9): 2888–2896.
91.
HussainM., HerrmannM., von EiffC., Perdreau-RemingtonF., PetersG.A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun.1997; 65(2): 519–524.
92.
HeilmannC., ThummG., ChhatwalG.S., HartleibJ., UekötterA., PetersG.Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology.2003; 149(Pt 10): 2769–2778.
93.
RuppM.E., FeyP.D., HeilmannC., GötzF.Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis.2001; 183(7): 1038–1042.
94.
ParkP.W., RosenbloomJ., AbramsW.R., RosenbloomJ., MechamR.P.Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. J Biol Chem.1996; 271(26): 15803–15809.
95.
BowdenM.G., VisaiL., LongshawC.M., HollandK.T., SpezialeP., HookM.Is the Geh D lipase from Staphylococcus epidermidis a collagen binding adhesin?J Biol Chem.2002; 277(45): 43017–43023.
96.
WilliamsR.J., HendersonB., SharpL.J., NairS.P.Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun.2002; 70(12): 6805–6810.
97.
VeenstraG.J., CremersF.F., van DijkH., FleerA.Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol.1996; 178(2): 537–541.
98.
HussainM., HeilmannC., PetersG., HerrmannM.Teichoic acid enhances adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog.2001; 31(6): 261–270.
99.
TojoM., YamashitaN., GoldmannD.A., PierG.B.Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis.1988; 157(4): 713–722.
100.
ArciolaC.R., BaldassarriL., MontanaroL.In catheter infections by Staphylococcus epidermidis the intercellular adhesion (ica) locus is a molecular marker of the virulent slime-producing strains. J Biomed Mater Res.2002; 59(3): 557–562.
101.
ArciolaC.R., CampocciaD., GamberiniS.. Search for the insertion element IS256 within the ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterial-associated infections. Biomaterials.2004; 25(18): 4117–4125.
102.
CenniE., GranchiD., ArciolaC.R.. Adhesive protein expression on endothelial cells after contact in vitro with polyethylene terephthalate coated with pyrolytic carbon. Biomaterials.1995; 16(16): 1223–1227.
103.
CampocciaD., ArciolaC.R., CervellatiM., MaltarelloM.C., MontanaroL.In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials.2003; 24(4): 587–596.
104.
ArciolaC.R., RadinL., AlvergnaP., CenniE., PizzoferratoA.Heparin surface treatment of poly(methylmethacrylate) alters adhesion of a Staphylococcus aureus strain: utility of bacterial fatty acid analysis. Biomaterials.1993; 14(15): 1161–1164.
105.
ArciolaC.R., CaramazzaR., PizzoferratoA.In vitro adhesion of Staphylococcus epidermidis on heparin-surface-modified intraocular lenses. J Cataract Refract Surg.1994; 20(2): 158–161.
106.
MontanaroL., CampocciaD., ArciolaC.R.Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials.2007; 28(34): 5155–5168.
107.
Walkowiak-PrzybyloM., KlimekL., OkrójW.. Adhesion, activation, and aggregation of blood platelets and biofilm formation on the surfaces of titanium alloys Ti6Al4V and Ti6Al7Nb. J Biomed Mater Res A.2012; 100(3): 768–775.
108.
LegeayG., Poncin-EpaillardF., ArciolaC.R.New surfaces with hydrophilic/hydrophobic characteristics in relation to (no) bioadhesion. Int J Artif Organs.2006; 29(4): 453–461.
109.
BruellhoffK., FiedlerJ., MöllerM., GrollJ., BrennerR.E.Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs.2010; 33(9): 646–653.
110.
PalacioM.L.B., BhushanB.Bioadhesion: a review of concepts and applications. Philos Transact A Math Phys Eng Sci.2012; 370(1967): 2321–2347.
111.
HuangJ., PengX., XiongC., FangJ.Influence of substrate rigidity on primary nucleation of cell adhesion: a thermal fluctuation model. J Colloid Interface Sci.2012; 366(1): 200–208.
112.
FiedlerJ., KolitschA., KleffnerB., HenkeD., StengerS., BrennerR.E.Copper and silver ion implantation of aluminium oxide-blasted titanium surfaces: proliferative response of osteoblasts and antibacterial effects. Int J Artif Organs.2011; 34(9): 882–888.
113.
ArciolaC.R., BustanjiY., ContiM.. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials.2003; 24(18): 3013–3019.
114.
BustanjiY., ArciolaC.R., ContiM., MandelloE., MontanaroL., SamoríB.Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc Natl Acad Sci USA.2003; 100(23): 13292–13297.
115.
FreneyJ., BrunY., BesM.. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Evol Microbiol.1988; 38(2): 168–172.
116.
HuebnerJ., GoldmannD.A.Coagulase-negative staphylococci: role as pathogens. Annu Rev Med.1999; 50: 223–236.
117.
von EiffC., ArciolaC.R., MontanaroL., BeckerK., CampocciaD.Emerging Staphylococcus species as new pathogens in implant infections. Int J Artif Organs.2006; 29(4): 360–367.
118.
ArciolaC.R., CampocciaD., GamberiniS., CervellatiM., DonatiE., MontanaroL.Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials.2002; 23(21): 4233–4239.
119.
ArciolaC.R., BaldassarriL., CampocciaD.. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials.2008; 29(5): 580–586.
120.
Di RosaR., CretiR., VendittiM.. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett.2006; 256(1): 145–150.
121.
DiekemaD.J., PfallerM.A., SchmitzF.J.. SENTRY Partcipants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis.2001; 32(Suppl 2): S114–S132.
122.
FrankK.L., Del PozoJ.L., PatelR.From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev.2008; 21(1): 111–133.
123.
KlotchkoA., WallaceM.R., LicitraC., SiegerB.Staphylococcus lugdunensis: an emerging pathogen. South Med J.2011; 104(7): 509–514.
124.
SotutuV., CarapetisJ., WilkinsonJ., DavisA., CurtisN.The “surreptitious Staphylococcus”: Staphylococcus lugdunensis endocarditis in a child. Pediatr Infect Dis J.2002; 21(10): 984–986.
125.
MitchellJ., TristanA., FosterT.J.Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology.2004; 150(Pt 11): 3831–3841.
126.
GeogheganJ.A., GaneshV.K., SmedsE., LiangX., HöökM., FosterT.J.Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen. J Biol Chem.2010; 285(9): 6208–6216.
127.
DonvitoB., EtienneJ., DenoroyL., GreenlandT., BenitoY., VandeneschF.Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect Immun.1997; 5(1): 95–100.
128.
PaulssonM., PeterssonA.C., LjunghA.Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J Med Microbiol.1993; 38(2): 96–102.
129.
FournierB., PhilpottD.J.Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev.2005; 18(3): 521–540.
130.
PietrocolaG., ArciolaC.R., RindiS.. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs.2011; 34(9): 799–810.
131.
BollerT., FelixG.A renaissance of elicitors: perception of microbe-associated molecular patterns and danger signals by pattern-recognition receptors. Annu Rev Plant Biol.2009; 60: 379–406.
132.
RautenbergM., JooH.S., OttoM., PeschelA.Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J.2011; 25(4): 1254–1263.
133.
VerhoefJ.The phagocytic process and the role of complement in host defense. J Chemother.1991; 3(Suppl 1): 93–97.
134.
ZimmerliW., ZarthA., GratwohlA., SpeckB.Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood.1991; 77(2): 393–399.
135.
CostertonJ.W., MontanaroL., ArciolaC.R.Biofilm in implant infections: its production and regulation. Int J Artif Organs.2005; 28(11): 1062–1068.
136.
NobleM.A., ReidP.E., ParkC.M., ChanV.Y.Inhibition of human neutrophil bacteriocidal activity by extracellular substance from slime-producing Staphylococcus epidermidis. Diagn Microbiol Infect Dis.1986; 4(4): 335–339.
137.
RodgersJ., PhillipsF., OlliffC.The effects of extracellular slime from Staphylococcus epidermidis on phagocytic ingestion and killing. FEMS Immunol Med Microbiol.1994; 9(2): 109–115.
138.
KristianS.A., BirkenstockT.A., SauderU., MackD., GötzF., LandmannR.Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis.2008; 197(7): 1028–1035.
139.
KaplanS.S., HeineR.P., SimmonsR.L.Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect Immun.1999; 67(4): 1640–1645.
140.
ArciolaC.R.Host defense against implant infection: the ambivalent role of phagocytosis. Int J Artif Organs.2010; 33(9): 565–567.
141.
JohnsonG.M., LeeD.A., RegelmannW.E., GrayE.D., PetersG., QuieP.G.Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun.1986; 54(1): 13–20.
142.
MyrvikQ.N., WagnerW., BarthE., WoodP., GristinaA.G.Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J Invest Surg.1989; 2(4): 381–389.
143.
ShanbhagA., YangJ., LilienJ., BlackJ.Decreased neutrophil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in vitro. J Biomed Mater Res.1992; 26(2): 185–195.
144.
LeidJ.G., ShirtliffM.E., CostertonJ.W., StoodleyP.Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun.2002; 70(11): 6339–6345.
145.
WatanabeI., IchikiM., ShiratsuchiA., NakanishiY.TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol.2007; 178(8): 4917–4925.
146.
ThurlowL.R., HankeM.L., FritzT.. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol.2011; 186(11): 6585–6596.
147.
MeyleE., Brenner-WeissG., ObstU., PriorB., HänschG.M.Immune defence against S. epidermidis biofilms: components of the extracellular polymeric substance activate distinct bactericidal mechanisms of phagocytic cells. Int J Artif Organs.2012; 35: 700–712.
148.
GuentherF., StrohP., WagnerC., ObstU., HänschG.M.Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. Int J Artif Organs.2009; 32(9): 565–573.
149.
HänschG.M., Brenner-WeissG., PriorB., WagnerC., ObstU.The extracellular polymer substance of Pseudomonas aeruginosa: too slippery for neutrophils to migrate on?Int J Artif Organs.2008; 31(9): 796–803.
150.
AndersonJ.M.Inflammation, wound healing, and the foreign-body response. In: RatnerB.D., HoffmanA.S., SchoenF.J., LemonsJ.E., eds. Biomaterials Science. (2004) An introduction to materials in medicine Elsevier, San Diego, CA. pp 296–304.
151.
AderemA., UnderhillD.M.Mechanisms of phagocytosis in macrophages. Annu Rev Immunol.1999; 17: 593–623.
152.
UnderhillD.M., OzinskyA.Phagocytosis of microbes: complexity in action. Annu Rev Immunol.2002; 20: 825–852.
CohnZ.A., HirschJ.G.The influence of phagocytosis on the intracellular distribution of granule-associated components of polymorphonuclear leucocytes. J Exp Med.1960; 112: 1015–1022.
155.
MackD., FischerW., KrokotschA.. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol.1996; 178(1): 175–183.
VuongC., KocianovaS., VoyichJ.M.. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem.2004; 279(52): 54881–54886.
158.
VuongC., VoyichJ.M., FischerE.R.. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol.2004; 6(3): 269–275.
159.
ForsgrenA., NordströmK.Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann NY Acad Sci.1974; 236(0): 252–266.
160.
LangoneJ.J.Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol.1982; 32: 157–252.
161.
de HaasC.J., VeldkampK.E., PeschelA.. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med.2004; 199(5): 687–695.
162.
RooijakkersS.H., RuykenM., RoosA.. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol.2005; 6(9): 920–927.
163.
LiuG.Y., EssexA., BuchananJ.T.. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med.2005; 202(2): 209–215.
164.
DeLeoF.R., DiepB.A., OttoM.Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am.2009; 23(1): 17–34.
165.
Sieprawska-LupaM., MydelP., KrawezykM.. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother.2004; 48(12): 4673–4679.
166.
LiM., ChaD.J., LaiY., VillaruzA.E., SturdevantD.E., OttoM.The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol.2007; 66(5): 1136–1147.
167.
JoubertO., VoegelinJ., GuilletV.. Distinction between pore assembly by staphylococcal alpha-toxin versus leukotoxins. J Biomed Biotechnol.2007 (1): 25935.
168.
McCormickJ.K., YarwoodJ.M., SchlievertP.M.Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol.2001; 55: 77–104.
169.
ZimmerliW., WaldvogelF.A., VaudauxP., NydeggerU.E.Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis.1982; 146(4): 487–497.
170.
ZimmerliW., LewP.D., WaldvogelF.A.Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest.1984; 73(4): 1191–1200.
171.
ChangS., PopowichY., GrecoR.S., HaimovichB.Neutrophil survival on biomaterials is determined by surface topography. J Vasc Surg.2003; 37(5): 1082–1090.
172.
WagnerC., KaksaA., MüllerW.. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate superoxides. Shock.2004; 22(2): 108–115.
173.
PapayannopoulosV., ZychlinskyA.NETs: a new strategy for using old weapons. Trends Immunol.2009; 30(11): 513–521.
MeyleE., StrohP., GüntherF., Hoppy-TichyT., WagnerC., HänschG.M.Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation. Int J Artif Organs.2010; 33(9): 608–620.
176.
FuchsT.A., AbedU., GoosmannC.. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol.2007; 176(2): 231–241.
177.
ThomasV.C., HancockL.E.Suicide and fratricide in bacterial biofilms. Int J Artif Organs.2009; 32(9): 537–544.
178.
TetzV.V., TetzG.V.Effect of extracellular DNA destruction by D Nase I on characteristics of forming biofilms. DNA Cell Biol.2010; 29(8): 399–405.
179.
WagnerC., KondellaK., BernschneiderT., HeppertV., WentzensenA., HänschG.M.Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection. Shock.2003; 20(6): 503–510.
180.
HusebyM.J., KruseA.C., DigreJ.. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc Natl Acad Sci USA.2010; 107(32): 14407–14412.
181.
MontanaroL., PoggiA., VisaiL.. Extracellular DNA in biofilms. Int J Artif Organs.2011; 34(9): 824–831.
182.
SavillJ., HaslettC.Fate of neutrophil. In: HellewellP.G., WilliamsT.J., eds. Immunopharmacology of neutrophils.San Diego, CA: Academic Press. 1994 pp. 295–314.
183.
SavillJ.Apoptosis in resolution of inflammation. J Leukoc Biol.1997; 61(4): 375–380.
184.
ZhangB., HirahashiJ., CullereX., MayadasT.N.Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem.2003; 278(31): 28443–28454.
185.
KobayashiS.D., VoyichJ.M., SomervilleG.A.. An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol.2003; 73(2): 315–322.
186.
WagnerC., ObstU., HänschG.M.Implant-associated posttraumatic osteomyelitis: collateral damage by local host defense?Int J Artif Organs.2005; 28(11): 1172–1180.
187.
MartinonF., BurnsK., TschoppJ.The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell.2002; 10(2): 417–426.
188.
RathinamV.A., VanajaS.K., FitzgeraldK.A.Regulation of inflammasome signaling. Nat Immunol.2012; 13(4): 333–2.
189.
FranchiL., Muñoz-PlanilloR., NúñezG.Sensing and reacting to microbes through the inflammasomes. Nat Immunol.2012; 13(4): 325–332.
190.
BueterC.L., LeeC.K., RathinamV.A.. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J Biol Chem.2011; 286(41): 35447–35455.
191.
MalikA.F., HoqueR., OuyangX.. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response. Proc Natl Acad Sci USA.2011; 13:108(50): 20095–100.
192.
FinkS.L., CooksonB.T.Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun.2005; 73(4): 1907–1916.
193.
SoongG., ChunJ., ParkerD., PrinceA.Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis.2012; 205(10): 1571–1579.
